| Dr Richard Alan Furie, MD | |
|
2800 Marcus Ave, Suite 200, New Hyde Park, NY 11042-1008 | |
| (516) 708-2550 | |
| (516) 708-2597 |
| Full Name | Dr Richard Alan Furie |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 45 Years |
| Location | 2800 Marcus Ave, New Hyde Park, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538175740 | NPI | - | NPPES |
| 00831865 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 142505 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Shore University Hospital | Manhasset, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore - Lij Medical Pc | 3375701568 | 5099 |
News Archive
Advitech Inc. ("Advitech" or the "Corporation") (TSX Venture Exchange: AVI) announced today that the TSX Venture Exchange Inc. (the "TSX-V") approved the previously announced consolidation of its issued and outstanding common shares on the basis of a ratio of eight pre-Consolidation shares for every one post-Consolidation share (the "Consolidation") and that the common shares of Advitech will be traded on a post-Consolidation basis starting November 26, 2009.
South Ural State University (SUSU) scientists together with colleagues from Spain, France, and Egypt have developed a model for more effective diagnosis of cardiovascular diseases and diabetes using artificial intelligence and Internet of Things technology.
A team of neuroscientists at the University of Leicester, UK, in collaboration with researchers from Poland and Japan, has announced a breakthrough in the understanding of the 'brain chemistry' that triggers our response to highly stressful and traumatic events.
In some parts of California, a higher percentage of children who were tested had elevated levels of toxic lead in their blood than in Flint, Michigan, during the height of that city's water crisis.
Orexigen® ( )Therapeutics, Inc today announced new data from the COR-I, COR-II and COR-Diabetes trials for Contrave® (bupropion SR/ naltrexone SR) to expand on top-line results announced in July. Contrave is the first of the Company's two late stage candidates for the treatment of obesity.
› Verified 3 days ago
| Entity Name | North Shore - Lij Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
Advitech Inc. ("Advitech" or the "Corporation") (TSX Venture Exchange: AVI) announced today that the TSX Venture Exchange Inc. (the "TSX-V") approved the previously announced consolidation of its issued and outstanding common shares on the basis of a ratio of eight pre-Consolidation shares for every one post-Consolidation share (the "Consolidation") and that the common shares of Advitech will be traded on a post-Consolidation basis starting November 26, 2009.
South Ural State University (SUSU) scientists together with colleagues from Spain, France, and Egypt have developed a model for more effective diagnosis of cardiovascular diseases and diabetes using artificial intelligence and Internet of Things technology.
A team of neuroscientists at the University of Leicester, UK, in collaboration with researchers from Poland and Japan, has announced a breakthrough in the understanding of the 'brain chemistry' that triggers our response to highly stressful and traumatic events.
In some parts of California, a higher percentage of children who were tested had elevated levels of toxic lead in their blood than in Flint, Michigan, during the height of that city's water crisis.
Orexigen® ( )Therapeutics, Inc today announced new data from the COR-I, COR-II and COR-Diabetes trials for Contrave® (bupropion SR/ naltrexone SR) to expand on top-line results announced in July. Contrave is the first of the Company's two late stage candidates for the treatment of obesity.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Alan Furie, MD 2800 Marcus Ave, Suite 200, New Hyde Park, NY 11042-1008 Ph: (516) 708-2550 | Dr Richard Alan Furie, MD 2800 Marcus Ave, Suite 200, New Hyde Park, NY 11042-1008 Ph: (516) 708-2550 |
News Archive
Advitech Inc. ("Advitech" or the "Corporation") (TSX Venture Exchange: AVI) announced today that the TSX Venture Exchange Inc. (the "TSX-V") approved the previously announced consolidation of its issued and outstanding common shares on the basis of a ratio of eight pre-Consolidation shares for every one post-Consolidation share (the "Consolidation") and that the common shares of Advitech will be traded on a post-Consolidation basis starting November 26, 2009.
South Ural State University (SUSU) scientists together with colleagues from Spain, France, and Egypt have developed a model for more effective diagnosis of cardiovascular diseases and diabetes using artificial intelligence and Internet of Things technology.
A team of neuroscientists at the University of Leicester, UK, in collaboration with researchers from Poland and Japan, has announced a breakthrough in the understanding of the 'brain chemistry' that triggers our response to highly stressful and traumatic events.
In some parts of California, a higher percentage of children who were tested had elevated levels of toxic lead in their blood than in Flint, Michigan, during the height of that city's water crisis.
Orexigen® ( )Therapeutics, Inc today announced new data from the COR-I, COR-II and COR-Diabetes trials for Contrave® (bupropion SR/ naltrexone SR) to expand on top-line results announced in July. Contrave is the first of the Company's two late stage candidates for the treatment of obesity.
› Verified 3 days ago
Dr. Farheen Hasan, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 27005 76th Ave, New Hyde Park, NY 11040 Phone: 718-470-7000 | |
Carylann Hadjiyane, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1991 Marcus Ave, Suite 101, New Hyde Park, NY 11042 Phone: 516-365-4949 Fax: 516-365-5462 | |
Paul S. Berg, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2001 Marcus Ave, Suite N204, New Hyde Park, NY 11042 Phone: 516-684-9229 Fax: 516-977-8589 | |
Dr. Michael Jason Levine, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1999 Marcus Ave Ste 220, New Hyde Park, NY 11042 Phone: 516-869-5400 Fax: 516-869-5800 | |
Gisele Wolf-klein, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 2800 Marcus Ave, Suite 200, New Hyde Park, NY 11042 Phone: 516-708-2522 Fax: 516-708-2570 | |
Dr. Monty Max Bodenheimer, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 3003 New Hyde Park Rd, Ste 406, New Hyde Park, NY 11042 Phone: 516-719-0102 Fax: 516-358-5403 | |
Michael Xin Chen, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 27005 76th Ave, New Hyde Park, NY 11040 Phone: 718-470-3377 |